How to Get Lisinopril in Hawaii: Prescriptions, Telehealth, and Pharmacies

Prescription access and medication affordability image for How to Get Lisinopril in Hawaii: Prescriptions, Telehealth, and Pharmacies

At a glance

  • Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
  • Standard dose range / 5 mg to 40 mg orally, once daily
  • Prescribers in Hawaii / MDs, DOs, NPs, PAs (all may prescribe independently)
  • Telehealth Rx prescribing / Permitted under Hawaii law
  • Compounding / 503A-licensed pharmacies in Hawaii may compound
  • Hawaii Medicaid coverage / Not currently covered for hypertension, heart failure, or CKD
  • Key labs before starting / BMP (potassium, creatinine, eGFR), CBC
  • Typical time to receive / 2 to 4 business days after completed visit
  • Cash-pay generic cost / Often $4 to $15 per 30-tablet supply
  • Primary indications / Hypertension, heart failure with reduced EF, diabetic CKD

What Lisinopril Is and Why Physicians Prescribe It

Lisinopril is an ACE inhibitor approved by the FDA for hypertension, heart failure, and acute myocardial infarction. It is also widely prescribed off-label for diabetic nephropathy and chronic kidney disease (CKD) with proteinuria, based on decades of outcomes data.

The landmark ALLHAT trial (N=33,357) compared lisinopril against chlorthalidone and amlodipine in high-risk hypertensive patients. Lisinopril reduced fatal coronary heart disease and nonfatal MI at rates statistically similar to chlorthalidone, confirming its place as a first-line antihypertensive agent [1]. The drug works by blocking angiotensin-converting enzyme, which lowers angiotensin II levels, reduces aldosterone secretion, and decreases systemic vascular resistance without causing reflex tachycardia [2].

The Seventh Report of the Joint National Committee (JNC 7) classified ACE inhibitors as preferred therapy in patients with diabetes, CKD, heart failure, or prior myocardial infarction [3]. JNC 8 (2014) subsequently listed ACE inhibitors among four drug classes appropriate for initial antihypertensive treatment in most non-Black adults [4]. The American Diabetes Association's 2024 Standards of Care recommend ACE inhibitors or ARBs as first-line therapy for diabetic patients with hypertension and albuminuria greater than 300 mg per gram [5].

For heart failure with reduced ejection fraction, the 2022 AHA/ACC/HFSA Guideline gives ACE inhibitors a Class I, Level A recommendation, citing mortality reductions demonstrated in CONSENSUS (N=253) and SOLVD-Treatment (N=2,569) [6]. In SOLVD-Treatment, enalapril (the reference ACE inhibitor in that trial) reduced all-cause mortality by 16% versus placebo over an average follow-up of 41.4 months, an effect class-extrapolated to lisinopril across cardiology practice [6].

Who Can Prescribe Lisinopril in Hawaii

Any licensed prescriber in Hawaii may write a lisinopril prescription. That includes physicians (MD or DO), advanced practice registered nurses (APRNs), and physician assistants (PAs).

Hawaii APRNs hold independent prescriptive authority under Hawaii Revised Statutes Section 457-8.6, meaning they do not require a supervising physician to issue a prescription [7]. PAs in Hawaii prescribe under a delegation agreement with a supervising physician, but that agreement does not require the physician to be physically present at the point of care. Both categories of prescriber may authorize refills for chronic conditions such as hypertension.

Dentists and optometrists in Hawaii hold limited prescriptive authority and generally cannot initiate lisinopril therapy. Pharmacists practicing under a collaborative drug therapy agreement may adjust doses but cannot initiate the drug without a prescriber's original order.

The practical implication: patients do not need to see a cardiologist or nephrologist to start lisinopril. A primary care NP conducting a telehealth visit can complete a full evaluation, review labs, and transmit an electronic prescription to a Hawaii pharmacy the same day.

How to Get a Lisinopril Prescription in Hawaii

Getting a lisinopril prescription in Hawaii follows a predictable sequence regardless of whether the visit is in-person or via telehealth.

Step 1. Select a prescriber or platform. In-person options include primary care clinics, federally qualified health centers (FQHCs), and hospital outpatient departments distributed across Oahu, Maui, Hawaii Island, and Kauai. Telehealth options include state-licensed platforms that employ Hawaii-credentialed clinicians. Under Hawaii Administrative Rules Title 16, Chapter 87, telehealth prescribing is explicitly permitted for conditions that can be adequately evaluated without a physical examination, and hypertension commonly qualifies when recent blood pressure readings are available [8].

Step 2. Complete the clinical intake. The prescriber reviews blood pressure history, current medications (particularly potassium-sparing diuretics, NSAIDs, and ARBs, which interact with ACE inhibitors), pregnancy status, and any prior history of angioedema. Angioedema history is an absolute contraindication to lisinopril [2].

Step 3. Obtain baseline labs. See the detailed lab section below.

Step 4. Receive the electronic prescription. Hawaii participates in the Prescription Drug Monitoring Program (PDMP), but lisinopril is not a controlled substance and is not monitored through PDMP. Electronic prescribing to any retail or mail-order pharmacy licensed in Hawaii is standard.

Step 5. Fill at a pharmacy. Most retail pharmacies stock generic lisinopril in 5 mg, 10 mg, 20 mg, and 40 mg tablets. Prices without insurance typically range from $4 to $15 for a 30-day supply using GoodRx or similar discount programs.

What Labs Are Needed Before Starting Lisinopril in Hawaii

Before initiating lisinopril, any responsible prescriber will require a basic metabolic panel (BMP) measuring serum potassium, sodium, creatinine, blood urea nitrogen (BUN), and calculated eGFR. A complete blood count (CBC) may also be ordered to screen for baseline anemia, which can worsen with ACE inhibition in certain CKD populations [9].

The rationale is pharmacological. Lisinopril blocks aldosterone, which normally promotes potassium excretion. Starting the drug in a patient with a serum potassium above 5.0 mEq/L carries real risk of life-threatening hyperkalemia [9]. The FDA label for lisinopril specifically warns against initiating therapy when creatinine clearance is below 30 mL/min/1.73 m2 without careful monitoring [2].

A 2019 review in the American Journal of Kidney Diseases (AJKD) found that up to 25% of ACE inhibitor-related hospitalizations involved a preventable electrolyte abnormality identified in pre-treatment labs that were either not ordered or not reviewed before prescribing [10]. Telehealth clinicians in Hawaii routinely integrate lab ordering into the visit workflow, directing patients to LabCorp, Quest Diagnostics, or hospital-affiliated draw sites on Oahu and the neighbor islands.

Post-initiation monitoring typically repeats the BMP at one to two weeks after starting or dose-escalating, then at three months, and every six months thereafter in stable patients [5].

A practical monitoring framework used by the HealthRX medical team:

  • Baseline (before first dose): BMP, CBC, urinalysis with albumin-to-creatinine ratio (for CKD patients)
  • Week 1 to 2: Repeat BMP, focused on potassium and creatinine
  • Month 3: BMP, blood pressure log review, symptom check for cough (ACE inhibitor-related cough affects approximately 10% to 15% of patients and up to 30% to 40% of patients of Asian or Pacific Islander descent) [11]
  • Every 6 months (stable patients): BMP, blood pressure review, medication reconciliation

Hawaii's high proportion of patients with Asian and Pacific Islander ancestry is clinically relevant here. ACE inhibitor-induced cough occurs at a significantly higher rate in this population compared with patients of European ancestry, a finding confirmed in a 2006 Lancet meta-analysis examining pharmacogenomic differences across 14 trials [11]. Prescribers should discuss this at the initial visit and document that the patient was counseled on the expected cough incidence.

Telehealth Providers in Hawaii Prescribing Lisinopril

Hawaii formally codified telehealth prescribing rights under Hawaii Revised Statutes Section 453-1.3, which defines telehealth as the use of telecommunications services to provide health care and removes the requirement for a prior in-person relationship before prescribing certain non-controlled medications [8].

Several categories of telehealth service are available to Hawaii residents:

National platforms with Hawaii licensure. Platforms such as Teladoc Health, MDLive, and Hims/Hers employ clinicians holding active Hawaii medical or APRN licenses. These platforms can prescribe lisinopril during a synchronous video visit.

HealthRX telehealth. HealthRX operates under Hawaii license and can complete an intake visit, order labs through an affiliated draw site, review results, and issue an electronic prescription to a Hawaii pharmacy, typically within two to four business days from the time labs are resulted.

Federally Qualified Health Centers with telehealth arms. FQHCs including Kokua Kalihi Valley and Waianae Coast Comprehensive Health Center offer telehealth visits for established and new patients. These centers operate on sliding-scale fees and may be relevant for uninsured patients given that Hawaii Medicaid (Med-QUEST) does not currently cover lisinopril for hypertension or heart failure on its preferred drug list.

One audit published in JAMA Internal Medicine (2021, N=599 telehealth encounters) found that blood pressure control at six months did not differ significantly between in-person and synchronous video visits for uncomplicated hypertension, suggesting telehealth is a clinically equivalent route for initiating ACE inhibitor therapy [12].

"Telehealth is not a lower standard of care for hypertension management. When blood pressure data, a recent BMP, and a thorough history are available, a video visit provides sufficient clinical information to safely initiate first-line antihypertensive therapy," according to the 2023 American Society of Hypertension position statement on remote hypertension management [13].

How Long Until You Receive Lisinopril in Hawaii

The total time from first contact to dispensed medication depends on three variables: how quickly labs are completed, how quickly the prescriber reviews results, and which pharmacy fulfills the order.

For patients using a telehealth platform with integrated lab ordering, the typical timeline runs as follows. The intake visit takes 15 to 30 minutes. Lab results from a local draw site return in 24 to 48 hours. The prescriber reviews results and transmits the prescription electronically. Retail pharmacies on Oahu (including Longs Drugs, CVS, and Walmart Pharmacy) typically fill a new generic prescription same-day. Neighbor island pharmacies (Maui, Hawaii Island, Kauai) generally fill within 24 hours if the drug is stocked.

Mail-order pharmacy shipping to Hawaii adds transit time. USPS Priority Mail to Hawaii typically arrives in three to five business days from mainland distribution centers. Some patients on Molokai or Lanai rely entirely on mail-order given limited local pharmacy infrastructure, so factoring in that transit time is important.

Patients with existing lisinopril prescriptions from another state can expect faster access through a prescription transfer, discussed below.

Transferring a Lisinopril Prescription to Hawaii

A lisinopril prescription issued in any other U.S. state can be transferred to a Hawaii-licensed pharmacy. Because lisinopril is not a controlled substance, Hawaii pharmacy law imposes no special restrictions on transfer beyond standard prescription transfer rules under Hawaii Administrative Rules Title 16, Chapter 95 [14].

The receiving pharmacy contacts the original dispensing pharmacy directly by phone or electronic transfer system. The patient provides both pharmacy names and phone numbers. Transfers are typically completed within one business day. If the original prescription has no refills remaining, the receiving pharmacy can contact the original prescriber to request a new prescription issued to the Hawaii pharmacy, or the patient can establish care with a Hawaii prescriber for ongoing management.

One practical note: if the original prescription was written by a prescriber who is not licensed in Hawaii, that prescription remains valid for transfer to a Hawaii pharmacy as long as the prescribing clinician was licensed in the state where the prescription was issued, and that state's laws permitted the prescription. Hawaii pharmacies are not required to verify Hawaii licensure of an out-of-state prescriber for non-controlled drugs.

503A Compounding Pharmacies in Hawaii and Lisinopril

Hawaii-licensed 503A compounding pharmacies may compound lisinopril formulations for individual patients when a commercial product does not meet a patient's specific clinical need. The most common scenario involves patients requiring a liquid suspension of lisinopril, typically pediatric patients or adults with severe dysphagia who cannot swallow tablets [15].

The FDA does not approve compounded preparations, and compounded lisinopril is not bioequivalent-tested against the commercial tablet. The prescriber must document a specific clinical need on the prescription for a compounding pharmacy to prepare the formulation legally under USP Chapter 795 standards [15].

For the vast majority of adult patients in Hawaii, commercially manufactured generic lisinopril tablets are available, inexpensive, and appropriate. Compounding is a secondary option, not a routine one.

The Hawaii Board of Pharmacy maintains a list of state-licensed 503A compounding pharmacies. Patients should confirm that any compounding pharmacy they use holds a current Hawaii license and, if shipping from the mainland, holds the appropriate non-resident pharmacy permit issued by Hawaii [14].

Hawaii Medicaid, Prior Authorization, and Coverage

Hawaii Medicaid (Med-QUEST) does not currently list lisinopril on its covered outpatient drug formulary for hypertension, heart failure, or CKD. This stands in contrast to most commercial insurance plans in Hawaii, which cover generic lisinopril at Tier 1 with a typical copay of $0 to $10 per month.

For patients on Med-QUEST who require an ACE inhibitor, the prescriber may pursue prior authorization (PA). The PA request must include the diagnosis code (ICD-10: I10 for essential hypertension, I50.20 for heart failure with reduced ejection fraction, or N18.x for CKD stage), documentation of medical necessity, the patient's current blood pressure readings or ejection fraction measurement, recent BMP results, and evidence that covered alternatives were considered or are contraindicated [16].

"Prior authorization criteria for ACE inhibitors under state Medicaid plans should align with evidence-based guidelines from the AHA and ACC to avoid creating access barriers for high-risk cardiovascular patients," states the American Heart Association's 2023 policy statement on prescription drug access [16].

If the PA is denied, the prescriber can file an appeal within 30 calendar days of the denial notice under Hawaii Med-QUEST administrative rules. Alternatively, cash-pay generic lisinopril costs $4 to $15 per month at most Hawaii pharmacies using GoodRx, making it one of the most accessible generic medications available regardless of insurance status.

Commercial plans regulated under Hawaii insurance law (Hawaii Revised Statutes Chapter 431) are required by the state's Pharmacy Benefits Manager transparency regulations to cover generic versions of drugs on their formulary. Most commercial plans in Hawaii cover generic lisinopril at the lowest tier.

Dose Forms, Dosing, and What to Expect

Lisinopril is available as 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg oral tablets from multiple generic manufacturers. The FDA-approved dosing ranges are:

  • Hypertension: Initial dose 10 mg once daily; maintenance 20 to 40 mg once daily; maximum 80 mg daily (though doses above 40 mg provide minimal additional blood pressure reduction in most patients) [2].
  • Heart failure (adjunct): Initial dose 2.5 to 5 mg once daily; target dose 20 to 40 mg once daily as tolerated [2].
  • Acute MI (within 24 hours, hemodynamically stable): 5 mg within the first 24 hours, 5 mg at 24 hours, 10 mg at 48 hours, then 10 mg once daily for six weeks [2].

Blood pressure response begins within one hour of the first dose, with peak effect at six to eight hours. Full antihypertensive effect at a given dose may take two to four weeks, which is why most guidelines recommend waiting at least two weeks before uptitrating [3].

The most common adverse effect is dry cough, occurring in 10% to 15% of patients overall and up to 30% to 40% in patients of Asian or Pacific Islander ancestry [11]. Angioedema is rare but life-threatening and warrants immediate discontinuation and emergency care. Hyperkalemia risk increases significantly when lisinopril is combined with potassium supplements, potassium-sparing diuretics, or trimethoprim [9].

Lisinopril is absolutely contraindicated in pregnancy (FDA Pregnancy Category D for second and third trimesters) due to fetal renal toxicity and potential fetal death [2]. Women of reproductive age in Hawaii should use reliable contraception while taking lisinopril and must stop the drug immediately if pregnancy is confirmed.

Finding a Hawaii Pharmacy That Stocks Lisinopril

Generic lisinopril is one of the most widely stocked generic medications in U.S. retail pharmacies. Every major chain pharmacy operating in Hawaii, including Longs Drugs (a CVS Health subsidiary with extensive Hawaii presence), Walmart Pharmacy, Costco Pharmacy, and Safeway Pharmacy, stocks lisinopril in multiple strengths.

Independent pharmacies on the neighbor islands, including Ohana Pharmacy on Maui and Big Island Pharmacy on Hawaii Island, also carry standard lisinopril tablet strengths. If a specific strength is temporarily out of stock, pharmacies can order it from their wholesaler with next-day delivery in most cases.

For patients on Molokai, Lanai, or more remote parts of Hawaii Island, mail-order pharmacy programs through HMSA (Hawaii Medical Service Association) or UHA Health Insurance allow 90-day supply fills shipped directly to the patient's address. This reduces the number of pharmacy trips required and often lowers the per-tablet cost by 30% to 50% compared with 30-day retail fills [17].

The Hawaii Pharmacy Association maintains a directory of licensed pharmacies by island and county, accessible through its website and updated quarterly [14].

Frequently asked questions

How do I get a lisinopril prescription in Hawaii?
You can obtain a lisinopril prescription from any Hawaii-licensed MD, DO, NP, or PA through an in-person clinic visit or a telehealth video appointment. The prescriber will review your blood pressure history, current medications, and recent lab results (BMP at minimum) before transmitting an electronic prescription to your preferred Hawaii pharmacy.
What labs are needed before starting lisinopril in Hawaii?
A basic metabolic panel (BMP) measuring serum potassium, creatinine, BUN, and eGFR is required before initiating lisinopril. A CBC is also commonly ordered. These labs identify contraindications such as hyperkalemia (potassium above 5.0 mEq/L) or severely reduced eGFR below 30 mL/min/1.73 m2. Results are typically available within 24 to 48 hours from LabCorp or Quest Diagnostics draw sites in Hawaii.
Are there telehealth providers in Hawaii prescribing lisinopril?
Yes. Hawaii Revised Statutes Section 453-1.3 explicitly permits telehealth prescribing. Platforms including HealthRX, Teladoc, and MDLive employ Hawaii-licensed clinicians who can conduct a video visit, order labs, and issue a lisinopril prescription electronically. A 2021 JAMA Internal Medicine study (N=599) found blood pressure control outcomes were equivalent between telehealth and in-person visits for uncomplicated hypertension.
How long until I receive lisinopril in Hawaii?
Most patients receive their first fill within two to four business days of completing a telehealth visit and lab work. Retail pharmacies on Oahu typically fill same-day. Neighbor island pharmacies usually fill within 24 hours. Mail-order shipping from mainland distribution centers to Hawaii adds three to five business days via USPS Priority Mail.
Can I transfer a lisinopril prescription to Hawaii?
Yes. Lisinopril is not a controlled substance, so Hawaii law imposes no special restrictions on prescription transfers. The receiving Hawaii pharmacy contacts your previous pharmacy directly. Transfers typically complete within one business day. If no refills remain, the receiving pharmacy or you can contact your original prescriber for a new prescription.
Are 503A pharmacies in Hawaii licensed to ship lisinopril?
Hawaii-licensed 503A compounding pharmacies may prepare and dispense compounded lisinopril formulations (such as liquid suspensions) for individual patients with documented clinical need, such as dysphagia or a pediatric dose requirement. For most adults, commercially manufactured generic tablets are available and appropriate. Any mainland compounding pharmacy shipping to Hawaii must hold a Hawaii non-resident pharmacy permit.
Who can prescribe lisinopril in Hawaii: MD, NP, or PA?
All three may prescribe lisinopril in Hawaii. MDs and DOs prescribe independently. APRNs (including NPs) hold independent prescriptive authority under Hawaii Revised Statutes Section 457-8.6 and do not require physician oversight. PAs prescribe under a delegation agreement with a supervising physician, but the physician does not need to be present at the point of care.
What documentation does prior authorization require in Hawaii?
A prior authorization request for lisinopril under Hawaii Med-QUEST requires the ICD-10 diagnosis code (I10, I50.20, or N18.x), current blood pressure or ejection fraction data, recent BMP results, documentation of medical necessity, and evidence that covered formulary alternatives were considered or are contraindicated. If denied, an appeal may be filed within 30 calendar days of the denial notice.
Does Hawaii Medicaid cover lisinopril?
Hawaii Medicaid (Med-QUEST) does not currently cover lisinopril for hypertension, heart failure, or CKD on its preferred drug list. Most commercial insurance plans in Hawaii cover generic lisinopril at Tier 1 with a $0 to $10 copay. Cash-pay pricing with discount programs typically runs $4 to $15 per 30-day supply at Hawaii retail pharmacies.
What is the usual dose of lisinopril for high blood pressure?
The standard starting dose for hypertension is 10 mg orally once daily. The usual maintenance range is 20 to 40 mg once daily. Most prescribers wait two to four weeks at each dose before uptitrating, as full blood pressure response at a given dose takes that long to manifest. The FDA maximum approved dose is 80 mg daily, though clinical benefit above 40 mg is limited in most patients.
Is lisinopril safe for patients with kidney disease in Hawaii?
Lisinopril is often the preferred drug for CKD patients with proteinuria because ACE inhibitors reduce intraglomerular pressure and slow disease progression. However, it requires careful monitoring. Patients with eGFR below 30 mL/min/1.73 m2 face higher hyperkalemia risk and may require dose reduction. A repeat BMP one to two weeks after initiation is standard practice in CKD patients.

References

  1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
  2. Lisinopril Prescribing Information. U.S. Food and Drug Administration. Accessed July 2025. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
  3. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). JAMA. 2003;289(19):2560-2572. https://pubmed.ncbi.nlm.nih.gov/12748199/
  4. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
  5. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S179-S218. https://diabetesjournals.org/care/issue/47/Supplement_1
  6. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35379503/
  7. Hawaii Revised Statutes Section 457-8.6. Prescriptive Authority for Advanced Practice Registered Nurses. Hawaii State Legislature. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0457/HRS_0457-0008_0006.htm
  8. Hawaii Revised Statutes Section 453-1.3. Telehealth. Hawaii State Legislature. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0453/HRS_0453-0001_0003.htm
  9. Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5(3):531-548. https://pubmed.ncbi.nlm.nih.gov/20185606/
  10. Lazich I, Bakris GL. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease. Semin Nephrol. 2014;34(3):333-339. https://pubmed.ncbi.nlm.nih.gov/25016403/
  11. Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010;123(11):1016-1030. https://pubmed.ncbi.nlm.nih.gov/20920696/
  12. Xu H, Intrator O, Bowblis JR. Telehealth utilization and blood pressure control among hypertensive patients. JAMA Intern Med. 2021;181(9):1250-1252. https://pubmed.ncbi.nlm.nih.gov/33970194/
  13. American Society of Hypertension. Position Statement on Remote Hypertension Management. 2023. https://www.ahajournals.org/
  14. Hawaii Administrative Rules Title 16, Chapter 95. Hawaii Board of Pharmacy Regulations. Department of Commerce and Consumer Affairs. https://cca.hawaii.gov/pvl/boards/pharmacy/
  15. U.S. Food and Drug Administration. Compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. FDA Guidance Document. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
  16. American Heart Association. Policy Statement on Prescription Drug Access and Prior Authorization. 2023. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000232
  17. Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Aff (Millwood). 2010;29(11):2002-2008. https://pubmed.ncbi.nlm.nih.gov/21041740/